Form 4: Director Elizabeth Murphy Lilly Trades Apogee Enterprises Stock

Director Elizabeth Murphy Lilly reported a transaction involving deferred restricted stock units for Apogee Enterprises, Inc. (APOG).

Summary

• Elizabeth Murphy Lilly, a Director at Apogee Enterprises, Inc., reported a transaction on June 24, 2026.
• The transaction involved the acquisition of 2,741 deferred restricted stock units (RSUs).
• These RSUs were granted under the 2019 Non-Employee Director Stock Plan.
• The RSUs will be settled in shares of common stock upon the reporting person's termination of service from the Board or other specified events.
• The value associated with the RSUs at the time of settlement is based on the common stock price.
• Following this transaction, Ms. Lilly beneficially owns 9,641 securities, including these deferred RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of director equity awards and does not contain performance-related information or strategic updates.

Positives

• Director Elizabeth Murphy Lilly continues to hold equity in Apogee Enterprises, Inc. through deferred stock units, indicating continued alignment with shareholder interests.
• The deferred stock units are part of a formal director compensation plan, suggesting a structured approach to incentivizing board members.

Negatives

• The filing only reports a change in beneficial ownership and does not provide details on the company's financial performance or strategic direction.

Risks

• The value of the deferred stock units is subject to the future market price of Apogee Enterprises' common stock, which carries inherent market risk.
• The settlement of RSUs is contingent upon the reporting person's termination of service, which is an uncertain future event.

Future Outlook

The future outlook for the reported securities is tied to the performance of Apogee Enterprises, Inc.'s common stock and the reporting person's continued service on the Board.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not typically provide strategic insights. This filing indicates a routine equity grant to a director under an established plan.

Corporate Governance

Related Party Transactions

• The transaction involves a director of the company, Elizabeth Murphy Lilly, and the company's equity compensation plan.

Stakeholder Impact

• Shareholders: The transaction reflects a standard component of director compensation, which is a normal business expense. The deferred stock units may dilute ownership slightly upon settlement.
• Employees: No direct impact on employees is indicated by this filing.
• Management: The filing is a routine disclosure for management and board members.
• Creditors: No impact on creditors is indicated.

Next Steps

• Settlement of deferred restricted stock units upon reporting person's termination of service or other specified events.
• Continued monitoring of Apogee Enterprises, Inc.'s stock performance.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Elizabeth Murphy Lilly, Apogee Enterprises, APOG, Deferred Stock Units, Restricted Stock Units, Director Compensation, Beneficial Ownership